Eupraxia Pharmaceuticals Inc. (EPRX)
Nasdaq: EPRX · Pharmaceutical Preparations · Victoria, BC · filing with the SEC since 2013
Who owns Eupraxia Pharmaceuticals Inc.
As filed with the SECHolders of 5% or more
3
Joseph S. Freedman holds 9% of Common Shares, no par value, as its SCHEDULE 13D/A filed Mar 16, 2026 says.
Directors and officers
0
report now, of 0 people on the record since . Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Joseph S. Freedman
SCHEDULE 13D/A · filed Mar 16, 2026 · Common Shares, no par value · 10.2% in Sep 26, 2025
Beutel, Goodman & Co Ltd.
SCHEDULE 13G · filed Nov 14, 2025 · Common Shares
Robert Disbrow
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Shares, with no par value
James E. Besser
SCHEDULE 13G/A · filed Aug 13, 2026 · Common Shares, no par value · reported falling below 5%, from 7.7% in May 12, 2026
What EPRX reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Euphraxia Pharma Inc
An entity · legal entity · owns, named in the 40-F filed Mar 13, 2026
Loan
An entity · legal entity · owns, named in the 40-F filed Mar 13, 2026
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.